Results 191 to 200 of about 22,921 (208)

Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival

Leukemia Research, 2014
Wolfgang R Sperr, Sonja Heibl, Reinhard Stauder   +2 more
exaly  

Concise Drug Review: Azacitidine and Decitabine

Oncologist, 2013
Jan H M Schellens, Jos Beijnen
exaly  

Azacitidine in adult patients with acute myeloid leukemia

Critical Reviews in Oncology/Hematology, 2017
Hartmut Döhner, John F Seymour, Pierre Fenaux   +2 more
exaly  

Activity of decitabine in patients with myelodysplastic syndrome previously treated with azacitidine

Leukemia and Lymphoma, 2008
Gautam Borthakur, Farhad Ravandi, Jean-Pierre J Issa   +2 more
exaly  

Low‐dose azacitidine after allogeneic stem cell transplantation for acute leukemia

Cancer, 2009
Elias J Jabbour, Hagop M Kantarjian, Guillermo Garcia-Manero   +2 more
exaly  

5-Azacitidine for myelodysplasia before allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation, 2009
William Earl Janssen
exaly  

Efficacy of Azacitidine in autoimmune and inflammatory disorders associated with myelodysplastic syndromes and chronic myelomonocytic leukemia

Leukemia Research, 2016
Arsene Mekinian, Eric Grignano, Jean-Emmanuel Kahn   +2 more
exaly  

Azacitidine for the treatment of lower risk myelodysplastic syndromes

Cancer, 2010
Pellegrino Musto, Luca Maurillo, Alessandra Spagnoli   +2 more
exaly  

Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher‐risk myelodysplastic syndromes

Cancer, 2011
Pierre Fenaux, Valeria Santini, Eva Hellström-Lindberg   +2 more
exaly  

Role of Human Nucleoside Transporters in the Uptake and Cytotoxicity of Azacitidine and Decitabine

Nucleosides, Nucleotides and Nucleic Acids, 2012
James D Young
exaly